Antithymocyte globuln rabbit
Products billed under this code include Thymoglobulin.
Payment limit per 25 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Thymoglobulin.
Payment limit per 25 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Thymoglobulin | Genzyme Corporation | 58468-0080-01 | 1 | $1,065.837 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $1,065.837 | +$8.046 | 25 MG | Antithymocyte globuln rabbit | v1, posted September 17, 2026 |
| 3Q26 | $1,057.791 | +$34.667 | 25 MG | Antithymocyte globuln rabbit | v1, posted September 15, 2026 |
| 2Q26 | $1,023.124 | +$13.372 | 25 MG | Antithymocyte globuln rabbit | v1, posted September 15, 2026 |
| 1Q26 | $1,009.752 | +$10.385 | 25 MG | Antithymocyte globuln rabbit | v1, posted September 15, 2026 |
| 4Q25 | $999.367 | +$2.975 | 25 MG | Antithymocyte globuln rabbit | v1, posted September 8, 2026 |
| 3Q25 | $996.392 | +$57.046 | 25 MG | Antithymocyte globuln rabbit | v1, posted March 10, 2026 |
| 2Q25 | $939.346 | −$10.918 | 25 MG | Antithymocyte globuln rabbit | v1, posted March 10, 2026 |
| 1Q25 | $950.264 | −$6.475 | 25 MG | Antithymocyte globuln rabbit | v1, posted December 19, 2025 |
| 4Q24 | $956.739 | +$0.727 | 25 MG | Antithymocyte globuln rabbit | v1, posted June 11, 2025 |
| 3Q24 | $956.012 | +$28.069 | 25 MG | Antithymocyte globuln rabbit | v1, posted June 11, 2025 |
| 2Q24 | $927.943 | −$1.083 | 25 MG | Antithymocyte globuln rabbit | v1, posted March 11, 2025 |
| 1Q24 | $929.026 | +$7.857 | 25 MG | Antithymocyte globuln rabbit | v1, posted December 19, 2024 |
| 4Q23 | $921.169 | +$0.635 | 25 MG | Antithymocyte globuln rabbit | v1, posted October 10, 2024 |
| 3Q23 | $920.534 | +$34.159 | 25 MG | Antithymocyte globuln rabbit | v1, posted June 5, 2024 |
| 2Q23 | $886.375 | −$2.619 | 25 MG | Antithymocyte globuln rabbit | v1, posted February 23, 2024 |
| 1Q23 | $888.994 | −$13.628 | 25 MG | Antithymocyte globuln rabbit | v1, posted December 6, 2023 |
| 4Q22 | $902.622 | +$5.914 | 25 MG | Antithymocyte globuln rabbit | v1, posted June 22, 2023 |
| 3Q22 | $896.708 | +$53.767 | 25 MG | Antithymocyte globuln rabbit | v1, posted June 9, 2023 |
| 2Q22 | $842.941 | +$4.613 | 25 MG | Antithymocyte globuln rabbit | v1, posted December 14, 2022 |
| 1Q22 | $838.328 | +$0.909 | 25 MG | Antithymocyte globuln rabbit | v1, posted June 8, 2022 |
| 4Q21 | $837.419 | −$8.135 | 25 MG | Antithymocyte globuln rabbit | v1, posted June 2, 2022 |
| 3Q21 | $845.554 | +$50.562 | 25 MG | Antithymocyte globuln rabbit | v1, posted June 2, 2022 |
| 2Q21 | $794.992 | +$4.391 | 25 MG | Antithymocyte globuln rabbit | v1, posted March 1, 2022 |
| 1Q21 | $790.601 | – | 25 MG | Antithymocyte globuln rabbit | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.